| Product NDC: | 67919-011 |
| Proprietary Name: | Cubicin |
| Non Proprietary Name: | Daptomycin |
| Active Ingredient(s): | 500 mg/10mL & nbsp; Daptomycin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67919-011 |
| Labeler Name: | Cubist Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021572 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030912 |
| Package NDC: | 67919-011-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (67919-011-01) > 10 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 67919-011-01 |
| Proprietary Name | Cubicin |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (67919-011-01) > 10 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 67919-011 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Daptomycin |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20030912 |
| Marketing Category Name | NDA |
| Labeler Name | Cubist Pharmaceuticals, Inc. |
| Substance Name | DAPTOMYCIN |
| Strength Number | 500 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient] |